11 Dec 2018
In the National Health Insurance (JKN), drug governance have to implement quality control and cost control. The Government has published the National Formulary (FORNAS) as quality control and e-catalogue as price control. FORNAS and e-catalogue are expected to minimize corruption practices in drug prescription and drug procurement. Quality and cost effective drugs have been selected in FORNAS. Use of drug and restrictions are also regulated for each level of health facilities to avoid irrational using. FORNAS is expected to reduce corruption by eliminating bribery/gratification practices to doctors/hospitals by pharmaceutical companies. On the other hand, the corruption holes in the procurement are tried to be reduced through the e-catalogue system. A number of drugs needed have been tendered and negotiated by LKPP at the best price in e-catalogue. Health facilities can carry out drug procurement quickly and transparently without auction process. But in the process of applying FORNAS and e-catalogue as quality control, cost control and to minimize corruption, there are still problems that have not yet been able to reach their goals optimally. Mismatch number of drugs and item of drugs in FORNAS and e-catalogue, differences of drug lists in FORNAS with the Clinical Practice Guidelines (PPK), the absence of rules governing the minimum percentage of FORNAS in Hospital formularies, delays in drug display processes in e-catalogs and weaknesses in e-catalogue application is a series of problems that still hamper FORNAS and e-catalogue as solutions to prevent corruption in JKN drug governance. Relevant agencies (Ministry of Health and LKPP) need to make improvements in the form of regulations that encourage FORNAS compliance at each of the health facility level, fulfillment of FORNAS drug items in e-catalogue, availability of FORNAS in e-catalogue in early year and improvement of e-catalogue application features.
Copyrights © 2018